# To Evaluate Efficacy of Monotherapy of Oxcarbazepine Versus Combination of Gabapentin With Oxcarbazepine in the Management of Trigeminal Neuralgia

> **NCT07625410** · PHASE2,PHASE3 · COMPLETED · sponsor: **Rehman Medical Institute - RMI** · enrollment: 44 (actual)

## Conditions studied

- Effectiveness of Drugs Was Compared for Treating Trigeminal Neuralgia
- Pain
- Pain Management

## Interventions

- **DRUG:** oxcarbamezapine(300 mg twice daily)
- **DRUG:** combination therapy(oxcarbamezapine 300 mg twice daily and gabapentine)

## Key facts

- **NCT ID:** NCT07625410
- **Lead sponsor:** Rehman Medical Institute - RMI
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-01
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2026-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07625410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07625410, "To Evaluate Efficacy of Monotherapy of Oxcarbazepine Versus Combination of Gabapentin With Oxcarbazepine in the Management of Trigeminal Neuralgia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07625410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*